Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression02:07

Tumor Progression

3.6K
3.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intratumoral serotonin and antidepressants in glioblastoma patients: narrowing the uncertainties.

Journal of neuro-oncology·2026
Same author

Anonymization and visualization of health data and biomarkers.

NPJ digital medicine·2026
Same author

Associations between common mental disorders, cardiovascular risk factors and lifestyle in adults participating in targeted health dialogues in Sweden.

Preventive medicine reports·2026
Same author

Lakartidningen·2026
Same author

Rare germline variants contribute to glioma predisposition: Whole-genome analysis of a regional cohort of glioma patients.

Neuro-oncology advances·2026
Same author

Relationship between genetically determined telomere length and childhood glioma risk.

Acta neuropathologica communications·2026
Same journal

Overall survival following palliative immune checkpoint inhibitor treatment according to ECOG performance status: a large registry-based study.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Pathological characteristics and prognosis of very young patients with early breast cancer: a comparative analysis with older patients.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Recent survival trends in the most fatal cancers in the Nordic countries: gains in some but not in all.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

First-in-human quantitative [¹⁵O]H₂O PET imaging of tumour blood flow at rest and during exercise in lymphoma patients.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Starshot field configuration in the linac isocentre size determination: a comparison of film and electronic portal imaging device measurements.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Perspectives on artificial intelligence-generated chronic disease risk predictions in early breast cancer: an international survey among radiation oncologists.

Acta oncologica (Stockholm, Sweden)·2026
See all related articles

Related Experiment Video

Updated: Mar 29, 2026

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

28.5K

Recent developments in brain tumor predisposing syndromes.

Gunnar Johansson1, Ulrika Andersson1, Beatrice Melin1

  • 1a Department of Radiation Sciences , Oncology, Umeå University , Umeå , Sweden.

Acta Oncologica (Stockholm, Sweden)
|December 5, 2015
PubMed
Summary
This summary is machine-generated.

Genetic advancements identify brain tumor predisposition syndromes. This review details common disorders like neurofibromatosis and Turcot syndrome, focusing on CNS tumors and targeted therapies.

More Related Videos

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.9K
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

8.3K

Related Experiment Videos

Last Updated: Mar 29, 2026

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

28.5K
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.9K
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

8.3K

Area of Science:

  • Genetics
  • Oncology
  • Neurology

Background:

  • The origins of most brain tumors remain unknown.
  • Genetic and DNA screening advances have identified numerous brain tumor predisposition disorders.
  • This review focuses on common genetic syndromes linked to brain tumors.

Purpose of the Study:

  • To review common genetic brain tumor predisposition disorders.
  • To discuss these disorders from genetic and clinical perspectives.
  • To highlight central nervous system (CNS) tumors and targeted therapies.

Main Methods:

  • Literature review of genetic brain tumor predisposition syndromes.
  • Analysis of genetic and clinical features of selected disorders.
  • Discussion of recent findings, including GLIOGENE collaboration and POT1 gene.

Main Results:

  • Identified common predisposition syndromes: neurofibromatosis types 1 and 2, schwannomatosis, rhabdoid tumor predisposition disorder, Gorlin syndrome, tuberous sclerosis complex, von Hippel-Lindau, Li-Fraumeni, and Turcot syndromes.
  • Detailed genetic and clinical differences based on germline mutations.
  • Highlighted CNS tumor prevalence and advancements in targeted therapies.

Conclusions:

  • Genetic factors play a significant role in brain tumor development.
  • Understanding specific genetic syndromes is crucial for clinical management.
  • Targeted therapies offer improved treatment options for CNS tumors in these disorders.